Salt Lake City, UT12 Active Studies

Pulmonary Embolism Clinical Trials in Salt Lake City, UT

Find 12 actively recruiting pulmonary embolism clinical trials in Salt Lake City, UT. Connect with local research sites and explore new treatment options.

12
Active Trials
12
Sponsors
2,127
Enrolling

Recruiting Pulmonary Embolism Studies in Salt Lake City

About Pulmonary Embolism Clinical Trials in Salt Lake City

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 12 pulmonary embolism clinical trials recruiting participants in Salt Lake City, UT. These studies are seeking a combined 2,127 participants. Research is being sponsored by Washington University School of Medicine, University of Vermont, University of Rochester and 9 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Salt Lake City — FAQ

Are there pulmonary embolism clinical trials in Salt Lake City?

Yes, there are 12 pulmonary embolism clinical trials currently recruiting in Salt Lake City, UT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Salt Lake City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you about next steps.

Are clinical trials in Salt Lake City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Salt Lake City studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 12 active trials in Salt Lake City are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 17, 2026 from ClinicalTrials.gov